Deuil la Barre, France

Marc Port

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 1.8

ph-index = 6

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 2001-2021

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Marc Port in Pharmaceutical Chemistry

Introduction

Marc Port, based in Deuil la Barre, France, is a notable inventor in the field of pharmaceutical chemistry, holding a remarkable 18 patents. His contributions primarily focus on innovative formulations and preparation methods for contrast agents used in medical imaging, showcasing his expertise and dedication to advancing medical technology.

Latest Patents

Marc Port's most recent patents include a "Contrast medium formulation and related preparation method," which describes a liquid pharmaceutical composition featuring a complex of a paramagnetic metal and a calcium complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid. This invention also details the preparation methods associated with the composition and methods of imaging that utilize this innovative formulation.

Another significant invention is the "Process for preparing a pharmaceutical formulation of contrast agents." This patent outlines a method for creating a liquid pharmaceutical formulation that contains a complex of macrocyclic chelate with a lanthanide, ensuring a precise and favorable composition is achieved. His careful measurements and adjustments in concentration contribute greatly to the efficacy of these formulations.

Career Highlights

Throughout his career, Marc Port has gained substantial experience working with prominent organizations. Notably, he has been associated with Guerbet, a company recognized for its specialization in contrast agents and imaging solutions. Additionally, Port has collaborated with the Université de Bordeaux, furthering research and development in pharmaceutical sciences.

Collaborations

Marc Port has had the opportunity to work alongside esteemed colleagues such as Claire Corot and Olivier Rousseaux. This collaborative environment has fostered innovative ideas and significant advancements in the field of pharmaceutical chemistry, particularly in the development of contrast media.

Conclusion

Marc Port's contributions to the pharmaceutical industry through his numerous patents and collaborations highlight his commitment to enhancing medical imaging technology. His innovative approaches in formulating contrast agents demonstrate how focused research and development can lead to significant advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…